Health care startups in San Diego, California
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Avenzo Therapeutics | San Diego | Series B | $60.0M | 2025-09-04 |
| Element Biosciences | San Diego | Series E | $277.0M | 2026-06-09 |
| Human Longevity | San Diego | Series B | $39.8M | 2024-08-21 |
| Condor Software | San Diego | Series A | $24.0M | 2026-03-18 |
| AristaMD | San Diego | Series C | $16.5M | 2023-11-14 |
| Gallant | San Diego | Series B | $18.0M | 2025-03-15 |
| Faro AI | San Diego | Series B | $37.3M | 2026-08-26 |
| Capstan Therapeutics | San Diego | Series B | $175.0M | 2024-03-20 |
8 rows of the CSV in 5 of its 18 columns.
- The 322 health care startups in San Diego, California have raised $15.0B in total.
- 37 of them closed their most recent round in the last 12 months, $1.8B combined.
- The largest of those rounds is Element Biosciences' $277.0M Series E, dated June 2026.
- The most recent is Theravie Pharma's $750K seed round on 8 October 2026.
- OrbiMed is an investor in 6 of them, more than any other fund.
- Biotech is the most common other sector, with 196 companies (61%).
- 28% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 11 to 50 employees (43% of companies with a recorded size).
- 2 are unicorns, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
22 of 322| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Faro AI | Faro AI develops software that automates clinical workflows and assists with clinical trial design. | Artificial intelligence | Series B | $37.3M | 2026-08-26 | $72.3M | General Catalyst, Polaris Partners, Zetta Venture Partners +2 | 11 to 50 | 2019 |
| Rybodyn | Rybodyn develops therapeutics that train the immune system to detect and eradicate cancer. | Biotech | Seed | $1.3M | 2026-07-23 | $15.3M | SOSV, SOSV SF & NY (Fka IndieBio) | 11 to 50 | 2022 |
| Element Biosciences Unicorn | Element Biosciences develops genomic sequencing and multiomics technologies for drug discovery and diagnostic applications. | Biotech | Series E | $277.0M | 2026-06-09 | $678.0M | RA Capital Management, Fidelity, Wellington Management +2 | 251 to 500 | 2017 |
| Condor Software | Condor Software is a financial intelligence platform that connects clinical, operational, and financial data in real time. | Biotech | Series A | $24.0M | 2026-03-18 | $29.5M | Plug and Play, MassChallenge, Pareto Holdings +1 | 11 to 50 | 2020 |
| Mirador Therapeutics | Mirador Therapeutics develops precision medicines for immune-mediated diseases. | Biotech | Series B | $250.0M | 2026-01-12 | $730.0M | OrbiMed, Fidelity, ARCH Venture Partners +1 | 11 to 50 | 2024 |
| BlossomHill Therapeutics | BlossomHill Therapeutics is a biopharmaceutical company focused on oncology and autoimmune disorders. | Biotech | Series B | $84.0M | 2025-12-10 | $257.0M | OrbiMed, Cormorant Asset Management, Vivo Capital +2 | 11 to 50 | 2020 |
| Aspen Neuroscience | Aspen Neuroscience is a biotechnology company that develops personalized cell therapies and autologous regenerative medicine. | Biotech | Series C | $115.0M | 2025-11-20 | $387.0M | Google Ventures, OrbiMed, EDBI +2 | 101 to 250 | 2018 |
| Avenzo Therapeutics | Avenzo Therapeutics develops oncology therapies for treating cancer. | Biotech | Series B | $60.0M | 2025-09-04 | $841.9M | New Enterprise Associates, Sands Capital Ventures, Lilly Asia Ventures +2 | 11 to 50 | 2022 |
| Actio Biosciences | Actio Biosciences develops drugs for rare diseases through its research center. | Biotech | Series B | $66.0M | 2025-06-18 | $121.0M | Canaan Partners, Euclidean Capital, Deerfield Management +2 | 11 to 50 | 2021 |
| Sirius Therapeutics | Sirius Therapeutics is a biotechnology company developing RNAi therapies for cardiovascular diseases. | Biotech | Series B | $50.0M | 2025-05-09 | $110.0M | OrbiMed, Hankang Capital, Creacion Ventures +1 | 11 to 50 | 2021 |
| Biolinq | Biolinq develops a wearable biosensor platform that measures blood level information. | Biotech | Series C | $100.0M | 2025-03-19 | $276.3M | Alpha Wave Global, Pegasus Tech Ventures, M Ventures | 51 to 100 | 2012 |
| Gallant | Gallant advances investigational stem cell therapies to extend the healthy years of pets. | Biotech | Series B | $18.0M | 2025-03-15 | $44.0M | Alumni Ventures, Bling Capital, Science +2 | 11 to 50 | 2018 |
| BioSapien | BioSapien is a biotech startup that provides a drug delivery platform for cancer treatment. | Biotech | Seed | $8.0M | 2024-12-13 | $45.1M | SOSV, National Science Foundation, SOSV SF & NY (Fka IndieBio) +2 | 1 to 10 | 2018 |
| Human Longevity Unicorn | Human Longevity is a genomics-based health intelligence company supporting proactive healthcare. | Biotech | Series B | $39.8M | 2024-08-21 | $369.8M | StartUp Health, Amino Capital, Threshold +1 | 51 to 100 | 2013 |
| Autobahn Therapeutics | Autobahn Therapeutics develops restorative treatments for neuropsychiatric and neuroimmunologic disorders. | Biotech | Series C | $100.0M | 2024-07-24 | $208.7M | Insight Partners, Invus, Bristol-Myers Squibb +2 | 11 to 50 | 2017 |
| Truvian Sciences | Truvian Sciences develops an automated benchtop system for lab-accurate blood testing. | Biotech | Series D | $74.0M | 2024-07-17 | $208.1M | General Catalyst, GreatPoint Ventures, Tao Capital Partners +2 | 101 to 250 | 2015 |
| Aardvark Therapeutics | Aardvark Therapeutics develops small molecule drugs for obesity and rare genetic metabolic disorders. | Biotech | Series C | $85.0M | 2024-05-09 | $129.0M | Cormorant Asset Management, Vickers Venture Partners, Decheng Capital +1 | 11 to 50 | 2017 |
| Capstan Therapeutics | Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases. | Biotech | Series B | $175.0M | 2024-03-20 | $340.0M | RA Capital Management, OrbiMed, Alexandria Venture Investments +2 | 101 to 250 | 2021 |
| AristaMD | AristaMD provides a software platform that helps hospitals and practitioners improve patient outcomes. | Health care | Series C | $16.5M | 2023-11-14 | $53.4M | Correlation Ventures, .406 Ventures, Avalon Ventures +1 | 11 to 50 | 2013 |
| Tentarix Biotherapeutics | Tentarix Biotherapeutics creates protein therapeutics with combined bioactivities using synthetic biology. | Biotech | Series B | $35.0M | 2023-09-06 | $93.0M | Versant Ventures, Samsara BioCapital, Amplitude Venture Capital | 11 to 50 | 2020 |
| Persephone Biosciences | Persephone Biosciences uses artificial intelligence to develop microbial-based immunotherapies for cancer. | Artificial intelligence | Seed | $15.0M | 2022-07-19 | $15.1M | Y Combinator, Pioneer Fund, ZhenFund +2 | 11 to 50 | 2017 |
| Liquid Grids | Liquid Grids helps healthcare companies monitor and engage in online health conversations. | Biotech | Series A | $699K | 2016-04-25 | $5.5M | TCA Venture Group, EvoNexus, Miramar Ventures | 11 to 50 | 2010 |
Table 1. Health care startups in San Diego, California: the 22 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 322.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Element Biosciences Unicorn | Element Biosciences develops genomic sequencing and multiomics technologies for drug discovery and diagnostic applications. | Biotech | Series E | $277.0M | 2026-06-09 | $678.0M | RA Capital Management, Fidelity, Wellington Management +2 | 251 to 500 | 2017 |
| 2 | Mirador Therapeutics | Mirador Therapeutics develops precision medicines for immune-mediated diseases. | Biotech | Series B | $250.0M | 2026-01-12 | $730.0M | OrbiMed, Fidelity, ARCH Venture Partners +1 | 11 to 50 | 2024 |
| 3 | Aspen Neuroscience | Aspen Neuroscience is a biotechnology company that develops personalized cell therapies and autologous regenerative medicine. | Biotech | Series C | $115.0M | 2025-11-20 | $387.0M | Google Ventures, OrbiMed, EDBI +2 | 101 to 250 | 2018 |
| 4 | BlossomHill Therapeutics | BlossomHill Therapeutics is a biopharmaceutical company focused on oncology and autoimmune disorders. | Biotech | Series B | $84.0M | 2025-12-10 | $257.0M | OrbiMed, Cormorant Asset Management, Vivo Capital +2 | 11 to 50 | 2020 |
| 5 | Faro AI | Faro AI develops software that automates clinical workflows and assists with clinical trial design. | Artificial intelligence | Series B | $37.3M | 2026-08-26 | $72.3M | General Catalyst, Polaris Partners, Zetta Venture Partners +2 | 11 to 50 | 2019 |
| 6 | Condor Software | Condor Software is a financial intelligence platform that connects clinical, operational, and financial data in real time. | Biotech | Series A | $24.0M | 2026-03-18 | $29.5M | Plug and Play, MassChallenge, Pareto Holdings +1 | 11 to 50 | 2020 |
| 7 | Rybodyn | Rybodyn develops therapeutics that train the immune system to detect and eradicate cancer. | Biotech | Seed | $1.3M | 2026-07-23 | $15.3M | SOSV, SOSV SF & NY (Fka IndieBio) | 11 to 50 | 2022 |
Table 2. Health care startups in San Diego, California: the 7 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | OrbiMed | Private equity firm | New York, United States | 6 | 2% | 3 | Mirador Therapeutics, BlossomHill Therapeutics, Aspen Neuroscience |
| 2 | New Enterprise Associates | Venture capital firm | Menlo Park, United States | 3 | 1% | ||
| 3 | S32 | Venture capital firm | San Diego, United States | 3 | 1% | 2 | Faro AI, Aspen Neuroscience |
| 4 | Alexandria Venture Investments | Venture capital firm | Pasadena, United States | 3 | 1% | 1 | Aspen Neuroscience |
| 5 | SOSV | Venture capital firm | Princeton, United States | 3 | 1% | 1 | Rybodyn |
| 6 | Blue Owl | Private equity firm | New York, United States | 3 | 1% | 1 | Mirador Therapeutics |
| 7 | EvoNexus | Startup accelerator | La Jolla, United States | 3 | 1% | ||
| 8 | Lilly Asia Ventures | Venture capital firm | Shanghai, China | 2 | 1% | ||
| 9 | Fidelity | Investment bank | Boston, United States | 2 | 1% | 2 | Element Biosciences, Mirador Therapeutics |
| 10 | RA Capital Management | Startup incubator | Boston, United States | 2 | 1% | 1 | Element Biosciences |
| 11 | MassChallenge | Startup accelerator | Boston, United States | 2 | 1% | 1 | Condor Software |
| 12 | Polaris Partners | Private equity firm | Boston, United States | 2 | 1% | 1 | Faro AI |
| 13 | General Catalyst | Venture capital firm | San Francisco, United States | 2 | 1% | 1 | Faro AI |
| 14 | Bristol-Myers Squibb | Venture capital firm | New York, United States | 2 | 1% | ||
| 15 | Cormorant Asset Management | Hedge fund | Boston, United States | 2 | 1% | 1 | BlossomHill Therapeutics |
Table 3. Health care startups in San Diego, California: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
Table 4. Health care startups in San Diego, California by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Health care startups in San Diego, California by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 3 | 8% | $80.8M |
| September 2026 | 1 | 3% | $50.0M |
| August 2026 | 3 | 8% | $113.3M |
| July 2026 | 5 | 14% | $134.6M |
| June 2026 | 6 | 16% | $308.7M |
| May 2026 | 3 | 8% | $240.5M |
| April 2026 | 6 | 16% | $242.3M |
| March 2026 | 3 | 8% | $55.9M |
| January 2026 | 4 | 11% | $283.3M |
| December 2025 | 2 | 5% | $214.0M |
| November 2025 | 1 | 3% | $115.0M |
Table 6. Health care startups in San Diego, California: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 34 | 11% | $1.5B |
| 2025 | 28 | 9% | $1.2B |
| 2024 | 32 | 10% | $1.0B |
| 2023 | 24 | 7% | $428.4M |
| 2022 | 28 | 9% | $576.1M |
| 2021 | 27 | 8% | $521.6M |
Table 7. Health care startups in San Diego, California by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 32 | 10% |
| 2020 to 2022 | 57 | 18% |
| 2015 to 2019 | 102 | 32% |
| 2010 to 2014 | 55 | 17% |
| Before 2010 | 73 | 23% |
Table 8. Health care startups in San Diego, California by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 121 | 39% |
| 11 to 50 | 134 | 43% |
| 51 to 100 | 31 | 10% |
| 101 to 250 | 13 | 4% |
| 251 to 500 | 9 | 3% |
| 501 to 1,000 | 1 | 0% |
| 1,001 to 5,000 | 1 | 0% |
| 5,001 to 10,000 | 2 | 1% |
Table 9. Health care startups in San Diego, California by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its headquarters is in San Diego, California. On 16 November 2026 that is 322 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 22 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 322 rows: 57 have no round amount, 0 no city and 51 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in San Diego, California are on the list?
- 322, in the file dated 16 November 2026. 37 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 322 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.